MSD Animal Health has announced the launch of Bravecto (fluralaner) Spot-On Solution for cats, a spot-on treatment for fleas and ticks effective for 12 weeks following a single dose. 

Amanda Melvin, Senior Product Manager, said: "We’re very excited about this approval as it will allow us to build on the success of our Bravecto chewable tablets for dogs and provide veterinarians and cat owners with another tool in the fight against ticks and fleas. Being able to offer a full 12 week protection means convenience for cat owners and improved compliance rates for veterinarians, so everyone benefits."

Bravecto is applied topically using the new "Twist’n’Use" pipette design which means the cap doesn’t need to be removed.  

Full product details are described in the summary of product characteristics (SPC). 

For more information, contact your MSD Animal Health representative.

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.